MedTrace Logo

Pharmacokinetic Study of Paracetamol.

NCT03953287 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2019-05-16

No results posted yet for this study

Summary

Brief Summary:

The study evaluate the absorption rate and pharmacodynamic of different formulation of paracetamol either in the form of normal tablets or a new rapid absorbable gelation capsule formulation "Paracetamol1523" by determining T-max and area under the response curve of paracetamol in blood concentration as well as from clinical effects after intake. Data is entered on data sheet in anonymous form and processed. The results are presented in anonymous form by publication and lecture. Experts are given the supplement: "The applicant's rights in a biomedical research project

Conditions

  • Pharmacological Action

Interventions

DRUG

Paracetamol

A randomized, cross over design

Sponsors & Collaborators

  • Kolding Sygehus

    lead OTHER

Principal Investigators

  • ole Rasmussen, M.D. · Medical Dept.,Kolding Hospital, SLB, Denmark

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-18
Primary Completion
2019-12-05
Completion
2020-02-03

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03953287 on ClinicalTrials.gov